4.7 Review

Upconversion Nanostructures Applied in Theranostic Systems

Journal

Publisher

MDPI
DOI: 10.3390/ijms23169003

Keywords

upconversion nanomaterials; theranostic system; lanthanide-doped upconversion nanoparticles; triplet-triplet annihilation upconversion; biosensing; drug carriers; NIR-triggered drug delivery; metal-organic frameworks

Funding

  1. Natural Sciences and Engineering Research Council of Canada (NSERC)

Ask authors/readers for more resources

This review investigates the applications of upconversion (UC) nanostructures in therapeutic systems. Lanthanide (Ln)-doped UC nanostructures can be used for therapeutic systems and organic molecular-based UC nanostructures have high UC quantum yields and do not require high excitation power due to the triplet-triplet annihilation (TTA) UC mechanism. The review also summarizes the current progress in the diagnosis and therapy using UC nanostructures and provides insight into future developments.
Upconversion (UC) nanostructures, which can upconvert near-infrared (NIR) light with low energy to visible or UV light with higher energy, are investigated for theranostic applications. The surface of lanthanide (Ln)-doped UC nanostructures can be modified with different functional groups and bioconjugated with biomolecules for therapeutic systems. On the other hand, organic molecular-based UC nanostructures, by using the triplet-triplet annihilation (TTA) UC mechanism, have high UC quantum yields and do not require high excitation power. In this review, the major UC mechanisms in different nanostructures have been introduced, including the Ln-doped UC mechanism and the TTA UC mechanism. The design and fabrication of Ln-doped UC nanostructures and TTA UC-based UC nanostructures for theranostic applications have been reviewed and discussed. In addition, the current progress in the application of UC nanostructures for diagnosis and therapy has been summarized, including tumor-targeted bioimaging and chemotherapy, image-guided diagnosis and phototherapy, NIR-triggered controlled drug releasing and bioimaging. We also provide insight into the development of emerging UC nanostructures in the field of theranostics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available